ATAI

Ataibeckley INC

+$123.8M

Net Activity

Institutions Holding

186

Popularity Rank

#3079

Avg Weight

0.08%

Total Value

$356.4M

Ownership Trend

186 institutions currently hold ATAI, with 166 net buyers and 123 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

123

Net Buying Institutions

166

Key Holders

Key Holders

Top 5 by Value

DT
Deep Track Capital, LP
$42.5M
VC
Vanguard Capital Management LLC
$41.6M
UG
UBS Group AG
$26.3M
BI
BlackRock, Inc.
$24.2M
SI
Susquehanna International Group, LLP
$21.2M

Top 5 by Conviction

BM
Brummer Multi-Strategy AB
4.06%
BU
Brown University
2.50%
FC
Foresite Capital Management VI LLC
2.12%
AC
Axon Capital LP
1.56%
EH
Eagle Health Investments LP
1.06%
View all 186 holding institutions

Quarterly Activity

Recent Activity

+$296.7M

Total Buy Value

$226.6M

Total Sell Value

New buy160
Trim4
Add6
Sold out119

166

Net Buyers

123

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

3

Filings (90d)

$1.08M

Total Est. Value

235K shares

Planned Shares

Last Filed 2026-07-07
FilerFiling DateEst. Value
ROBERT HERSHBERG2026-07-07$496K
Kochendoerfer Gerd2026-06-26$229K
Craig Kevin James2026-06-25$355K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-07-16
2026-07-16

ATAI (AtaiBeckley Inc.) has entered into a definitive merger agreement with Eli Lilly and Company. Under the terms, ATAI shareholders will receive $6.75 per share in cash at closing, plus one contingent value right (CVR) per share that could pay up to $2.50 in additional cash if specified clinical and regulatory milestones are achieved. The CVR milestones cover the advancement of VLS-01 and BPL-003 programs. The transaction, unanimously approved by ATAI's board, is subject to stockholder approval and antitrust clearance.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding ATAIBECKLEY INC (ATAI)?
Major stakeholders currently include Deep Track Capital, LP ($42.5M), Vanguard Capital Management LLC ($41.6M), UBS Group AG ($26.3M). Based on the latest 13F filings, there are a total of 186 tracked investment funds and institutions maintaining positions in ATAI.
What is the overall institutional sentiment toward ATAI recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $123.8M, driven by 166 managers accumulating shares while 123 reduced their exposure.
Which institutions have been selling or reducing their ATAI positions?
In the latest period, 4 funds trimmed their holdings, and 119 managers completely exited their positions. The aggregate reported sell value was $226.6M.
Are there any notable investors adding ATAI to their portfolios?
Yes, buying activity remains notable. 160 institutions opened new positions in {ticker}, and 6 existing holders added to their shares. The total reported buy value for the quarter amounted to $296.7M.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,150

Total reported value

$2.1T

3245 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,957

Total reported value

$1.5T

3028 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,764

Total reported value

$3.0T

2743 13F institutions increased their position this quarter

View detail